Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rural Population | 7 | 2019 | 2325 | 1.130 |
Why?
|
Uganda | 13 | 2023 | 1361 | 0.930 |
Why?
|
Respiratory Tract Diseases | 2 | 2019 | 744 | 0.870 |
Why?
|
Lung Diseases, Obstructive | 1 | 2022 | 311 | 0.720 |
Why?
|
Rural Health | 2 | 2019 | 302 | 0.720 |
Why?
|
HIV Infections | 10 | 2023 | 17569 | 0.690 |
Why?
|
Pulmonary Medicine | 2 | 2019 | 223 | 0.670 |
Why?
|
HIV Seroprevalence | 1 | 2019 | 89 | 0.660 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 3252 | 0.590 |
Why?
|
Spirometry | 5 | 2023 | 929 | 0.560 |
Why?
|
Organizational Objectives | 1 | 2019 | 426 | 0.550 |
Why?
|
Forced Expiratory Volume | 5 | 2023 | 1831 | 0.530 |
Why?
|
Respiration Disorders | 1 | 2019 | 364 | 0.520 |
Why?
|
Carbon Monoxide | 1 | 2019 | 560 | 0.510 |
Why?
|
Lung | 5 | 2023 | 10101 | 0.470 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2023 | 2204 | 0.460 |
Why?
|
Fellowships and Scholarships | 2 | 2019 | 1135 | 0.420 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2018 | 621 | 0.420 |
Why?
|
Language | 1 | 2022 | 1557 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3238 | 0.400 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1119 | 0.400 |
Why?
|
Teaching | 1 | 2019 | 1171 | 0.380 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2017 | 843 | 0.360 |
Why?
|
Emergency Medicine | 1 | 2019 | 1223 | 0.340 |
Why?
|
Vital Capacity | 3 | 2023 | 996 | 0.340 |
Why?
|
Patient Selection | 1 | 2020 | 4260 | 0.300 |
Why?
|
Women's Health | 2 | 2019 | 2082 | 0.290 |
Why?
|
Health Status Disparities | 3 | 2020 | 1885 | 0.270 |
Why?
|
Societies, Medical | 1 | 2019 | 3968 | 0.270 |
Why?
|
Atherosclerosis | 1 | 2022 | 3433 | 0.250 |
Why?
|
Respiratory Function Tests | 2 | 2022 | 1695 | 0.250 |
Why?
|
Long QT Syndrome | 2 | 2020 | 472 | 0.240 |
Why?
|
Air Pollution | 1 | 2019 | 2374 | 0.240 |
Why?
|
Research Design | 1 | 2020 | 6209 | 0.230 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 8052 | 0.230 |
Why?
|
Environmental Exposure | 1 | 2019 | 4543 | 0.230 |
Why?
|
Pandemics | 3 | 2021 | 8747 | 0.230 |
Why?
|
Lymphopenia | 1 | 2025 | 300 | 0.200 |
Why?
|
Enterocolitis | 1 | 2023 | 106 | 0.200 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2596 | 0.190 |
Why?
|
Virus Shedding | 1 | 2022 | 110 | 0.190 |
Why?
|
Risk Factors | 13 | 2024 | 74944 | 0.180 |
Why?
|
Platelet Transfusion | 1 | 2023 | 301 | 0.180 |
Why?
|
Saline Solution, Hypertonic | 1 | 2020 | 115 | 0.170 |
Why?
|
Sex Factors | 4 | 2019 | 10632 | 0.170 |
Why?
|
Diazepam | 1 | 2020 | 214 | 0.170 |
Why?
|
Anti-HIV Agents | 3 | 2021 | 4573 | 0.170 |
Why?
|
Pacific Ocean | 1 | 2019 | 16 | 0.160 |
Why?
|
Humans | 37 | 2025 | 768171 | 0.160 |
Why?
|
Cross-Sectional Studies | 8 | 2022 | 26379 | 0.160 |
Why?
|
HIV Long-Term Survivors | 1 | 2020 | 140 | 0.160 |
Why?
|
Poisoning | 1 | 2020 | 252 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 224 | 0.160 |
Why?
|
Heart Block | 1 | 2020 | 390 | 0.160 |
Why?
|
Eligibility Determination | 1 | 2022 | 421 | 0.160 |
Why?
|
Urban Health | 1 | 2021 | 535 | 0.160 |
Why?
|
Off-Label Use | 1 | 2020 | 185 | 0.150 |
Why?
|
ABO Blood-Group System | 1 | 2020 | 381 | 0.150 |
Why?
|
Limit of Detection | 1 | 2018 | 277 | 0.140 |
Why?
|
Health Personnel | 2 | 2022 | 3384 | 0.140 |
Why?
|
Carotid Arteries | 1 | 2022 | 942 | 0.140 |
Why?
|
Asia | 1 | 2019 | 630 | 0.140 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 283 | 0.140 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 452 | 0.130 |
Why?
|
Blood Transfusion | 1 | 2023 | 1309 | 0.130 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14783 | 0.130 |
Why?
|
Cohort Studies | 5 | 2022 | 41753 | 0.130 |
Why?
|
Prevalence | 5 | 2019 | 15869 | 0.130 |
Why?
|
Education, Medical, Graduate | 2 | 2019 | 2420 | 0.120 |
Why?
|
Macrophage Activation | 1 | 2018 | 557 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2020 | 570 | 0.120 |
Why?
|
Male | 20 | 2025 | 364731 | 0.120 |
Why?
|
Carotid Artery Diseases | 1 | 2021 | 879 | 0.120 |
Why?
|
Colitis | 1 | 2023 | 1242 | 0.120 |
Why?
|
Virus Replication | 1 | 2022 | 2458 | 0.110 |
Why?
|
Middle Aged | 14 | 2025 | 223487 | 0.110 |
Why?
|
Female | 18 | 2025 | 397187 | 0.110 |
Why?
|
Needs Assessment | 1 | 2019 | 1141 | 0.110 |
Why?
|
Critical Care | 4 | 2023 | 2715 | 0.110 |
Why?
|
Career Choice | 1 | 2019 | 769 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1406 | 0.100 |
Why?
|
Viral Load | 2 | 2020 | 3396 | 0.100 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 1191 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1457 | 0.100 |
Why?
|
Manometry | 1 | 2014 | 459 | 0.100 |
Why?
|
Electrocardiography | 3 | 2020 | 6412 | 0.090 |
Why?
|
Smoking | 2 | 2022 | 9092 | 0.090 |
Why?
|
Adult | 14 | 2025 | 223646 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2014 | 713 | 0.090 |
Why?
|
C-Reactive Protein | 2 | 2019 | 3858 | 0.080 |
Why?
|
Vaccination | 1 | 2022 | 3437 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2726 | 0.080 |
Why?
|
Influenza, Human | 1 | 2020 | 1541 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2819 | 0.080 |
Why?
|
Esophagus | 1 | 2014 | 1042 | 0.080 |
Why?
|
Aged | 8 | 2025 | 171502 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3229 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2018 | 2118 | 0.070 |
Why?
|
Lung Neoplasms | 1 | 2013 | 13586 | 0.070 |
Why?
|
Case-Control Studies | 3 | 2023 | 22290 | 0.070 |
Why?
|
Antigens, CD | 1 | 2018 | 4035 | 0.070 |
Why?
|
Logistic Models | 1 | 2022 | 13290 | 0.070 |
Why?
|
Population Surveillance | 1 | 2018 | 2596 | 0.070 |
Why?
|
Models, Theoretical | 1 | 2019 | 3573 | 0.070 |
Why?
|
Heart Rate | 1 | 2018 | 4214 | 0.070 |
Why?
|
Comorbidity | 2 | 2019 | 10590 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2018 | 2085 | 0.070 |
Why?
|
Risk Assessment | 4 | 2021 | 24318 | 0.060 |
Why?
|
Curriculum | 1 | 2019 | 3782 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3929 | 0.060 |
Why?
|
United States | 4 | 2021 | 73039 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9384 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1298 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2020 | 15662 | 0.050 |
Why?
|
Incidence | 1 | 2022 | 21538 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54924 | 0.050 |
Why?
|
Lymphocyte Count | 1 | 2025 | 794 | 0.050 |
Why?
|
Platelet Count | 1 | 2023 | 787 | 0.040 |
Why?
|
Young Adult | 4 | 2020 | 60066 | 0.040 |
Why?
|
Intubation | 1 | 2020 | 140 | 0.040 |
Why?
|
Respiratory Therapy | 1 | 2020 | 125 | 0.040 |
Why?
|
Appendectomy | 1 | 2023 | 444 | 0.040 |
Why?
|
Atrial Fibrillation | 1 | 2018 | 5176 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59626 | 0.040 |
Why?
|
Double-Blind Method | 2 | 2022 | 12466 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 752 | 0.030 |
Why?
|
Prognosis | 2 | 2020 | 30009 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2022 | 81760 | 0.030 |
Why?
|
Treatment Failure | 1 | 2020 | 2661 | 0.030 |
Why?
|
Adolescent | 2 | 2019 | 89169 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2022 | 3740 | 0.030 |
Why?
|
Disease Progression | 2 | 2021 | 13668 | 0.030 |
Why?
|
Cultural Competency | 1 | 2016 | 303 | 0.030 |
Why?
|
Life Expectancy | 1 | 2020 | 1248 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3628 | 0.030 |
Why?
|
Blood Platelets | 1 | 2023 | 2479 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1359 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18065 | 0.020 |
Why?
|
Time Factors | 2 | 2022 | 40220 | 0.020 |
Why?
|
International Cooperation | 1 | 2016 | 1436 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3345 | 0.020 |
Why?
|
Boston | 1 | 2020 | 9374 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3932 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1798 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2025 | 15949 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4091 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2022 | 65379 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 10397 | 0.010 |
Why?
|
Blood Glucose | 1 | 2019 | 6431 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15453 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3415 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10873 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12543 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7951 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
Clinical Competence | 1 | 2016 | 4858 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39354 | 0.010 |
Why?
|
Hypertension | 1 | 2014 | 8616 | 0.010 |
Why?
|
Concepts
(160)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(105)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_